These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25256148)

  • 1. The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus.
    van der Leeuw J; van Dieren S; Beulens JW; Boeing H; Spijkerman AM; van der Graaf Y; van der A DL; Nöthlings U; Visseren FL; Rutten GE; Moons KG; van der Schouw YT; Peelen LM
    Heart; 2015 Feb; 101(3):222-9. PubMed ID: 25256148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes.
    van Dieren S; Peelen LM; Nöthlings U; van der Schouw YT; Rutten GE; Spijkerman AM; van der A DL; Sluik D; Boeing H; Moons KG; Beulens JW
    Diabetologia; 2011 Feb; 54(2):264-70. PubMed ID: 21076956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
    Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings.
    Dziopa K; Asselbergs FW; Gratton J; Chaturvedi N; Schmidt AF
    Diabetologia; 2022 Apr; 65(4):644-656. PubMed ID: 35032176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.
    Brownrigg JR; de Lusignan S; McGovern A; Hughes C; Thompson MM; Ray KK; Hinchliffe RJ
    Heart; 2014 Dec; 100(23):1837-43. PubMed ID: 25095826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus.
    Echouffo-Tcheugui JB; Kengne AP
    Diabetes Metab; 2013 Oct; 39(5):389-96. PubMed ID: 24080092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register.
    Zethelius B; Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K; Cederholm J;
    Eur J Prev Cardiol; 2014 Feb; 21(2):244-51. PubMed ID: 24227183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Applications of the NDR and DIAL models for risk prediction on cardiovascular disease in patients with type 2 diabetes in Ningbo].
    Li QQ; Liang JY; Wang JM; Shen P; Sun YX; Chen Q; Wu JG; Lu P; Zhang JY; Lin HB; Tang X; Gao P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jun; 43(6):945-952. PubMed ID: 35725354
    [No Abstract]   [Full Text] [Related]  

  • 10. External Validation of a Tool Predicting 7-Year Risk of Developing Cardiovascular Disease, Type 2 Diabetes or Chronic Kidney Disease.
    Rauh SP; Rutters F; van der Heijden AAWA; Luimes T; Alssema M; Heymans MW; Magliano DJ; Shaw JE; Beulens JW; Dekker JM
    J Gen Intern Med; 2018 Feb; 33(2):182-188. PubMed ID: 29204973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are diabetes risk scores useful for the prediction of cardiovascular diseases? Assessment of seven diabetes risk scores in the KORA S4/F4 cohort study.
    Kowall B; Rathmann W; Bongaerts B; Thorand B; Belcredi P; Heier M; Huth C; Rückert IM; Stöckl D; Peters A; Meisinger C
    J Diabetes Complications; 2013; 27(4):340-5. PubMed ID: 23659777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
    Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
    Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic tools for cardiovascular disease in patients with type 2 diabetes: A systematic review and meta-analysis of C-statistics.
    Chowdhury MZI; Yeasmin F; Rabi DM; Ronksley PE; Turin TC
    J Diabetes Complications; 2019 Jan; 33(1):98-111. PubMed ID: 30446478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk predictive modelling for diabetes and cardiovascular disease.
    Kengne AP; Masconi K; Mbanya VN; Lekoubou A; Echouffo-Tcheugui JB; Matsha TE
    Crit Rev Clin Lab Sci; 2014 Feb; 51(1):1-12. PubMed ID: 24304342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review.
    van Dieren S; Beulens JW; Kengne AP; Peelen LM; Rutten GE; Woodward M; van der Schouw YT; Moons KG
    Heart; 2012 Mar; 98(5):360-9. PubMed ID: 22184101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into coronary heart disease (CHD) and stroke.
    van Kempen BJ; Ferket BS; Kavousi M; Leening MJ; Steyerberg EW; Ikram MA; Witteman JC; Hofman A; Franco OH; Hunink MG
    Int J Cardiol; 2014 Feb; 171(3):413-8. PubMed ID: 24438922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A newly developed and externally validated non-clinical score accurately predicts 10-year cardiovascular disease risk in the general adult population.
    Schiborn C; Kühn T; Mühlenbruch K; Kuxhaus O; Weikert C; Fritsche A; Kaaks R; Schulze MB
    Sci Rep; 2021 Oct; 11(1):19609. PubMed ID: 34608230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.
    Read SH; van Diepen M; Colhoun HM; Halbesma N; Lindsay RS; McKnight JA; McAllister DA; Pearson ER; Petrie JR; Philip S; Sattar N; Woodward M; Wild SH;
    Diabetes Care; 2018 Sep; 41(9):2010-2018. PubMed ID: 30002197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive performance of established cardiovascular risk scores in the prediabetic population: external validation using the UK Biobank data set.
    Li M; Lin Y; Zhong X; Huang R; Zhang S; Liu M; Liu S; Ye X; Xu X; Huang Y; Xiong Z; Guo Y; Liao X; Zhuang X
    Eur J Prev Cardiol; 2023 Oct; 30(14):1427-1438. PubMed ID: 37036042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.